Atypical vascular neoplasms and risk of development of angiosarcoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text component.
Since the introduction on the market in 1995 of Doxil, pegylated liposomal doxorubicin, liposomes have become one of the most clinically established drug delivery systems in nanomedicine. Among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback